Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: docetaxel|DRUG: doxorubicin hydrochloride|DRUG: zoledronic acid|PROCEDURE: neoadjuvant therapy
Sponsor: Borstkanker Onderzoek Groep
Collaborators: Dutch Cancer Society|Amgen|Sanofi|Novartis